Rapid, inexpensive, universal, on-site, pan-cancer evaluation; ultimately an inexpensive, universal, pan-cancer screening test.Press Release July 9, 2020
"License agreement creates golden opportunity for cancer diagnostic technology!"
A novel rapid cancer diagnostic technology with the potential to quickly and easily detect cancer has been licensed for further development.
AN ELECTRODE BASED METER THAT GENERATES A DIGITAL READOUT BASED ON THE AMOUNT OF CANCER DNA IN A PERSON’S BLOOD
THE "aiELECTRODE" IS SELECTIVELY SENSITIVE TO THE ALTERED METHYLATION PATTERN THAT IS CHARACTERISTIC OF ALL TYPES OF CANCER DNA TESTED.
Thus, the identification of epigenetic alterations “…improved cancer diagnosis and effective treatments”
Zhang W1, Xu J1.
Biomark Res. 2017; 5: 1.
The electrode's ability to separate blood from cancer patients and normal patients is extraordinary
Watch your treatment work!
Target, Kill and Confirm.
Typically, it takes 3-6 months for scans to show if a cancer is shrinking. "Pseudo-progression" is the term used when scans are wrong, showing an increase in size despite effective therapy.
TheraScape provides a true reading of cancer DNA from a simple blood test. The first use of TheraScape will be in trials of new drugs. Pharma wants to know early if a drug is working. Clinical trial research use is not FDA regulated.
CLIA lab(s) can provide the testing to doctors and patients so every person can be sure their therapy is working.
Current “personalized medicine” predicts which therapy will work for a cancer patient, unfortunately, like most predictions, it is inaccurate. For advanced cancers, although it improves the odds, more often it is wrong than right.
aiGENE does not predict, it measures. This “in-persona evaluation™” will provides accurate evaluation of immunotherapy before a second dose. TheraScape will enable an immediate and lifesaving switch.
Ultimately every oncologist will be able to do this test in their office and we believe will do it on all eligible patients before every new round of therapy.
Save lives by providing actionable information.
Help each cancer patient constantly receive optimal treatment by supplying overnight and ultimately immediate on-site results.